| Stage | ULS | % of rev | ZWS | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $816M | 100.00% | $495M | 100.00% | ULS ×1.65 |
| Gross profit | $417M | 51.10% | $246M | 49.65% | ULS +1.5pp |
| Operating income | $150M | 18.38% | $108M | 21.85% | ZWS +3.5pp |
| Pre-tax income | $338M | 41.42% | $103M | 20.72% | ULS +20.7pp |
| Net income | $254M | 31.13% | $76M | 15.41% | ULS +15.7pp |
| Stage | ULS | ZWS | Gap · A − B |
|---|---|---|---|
| Revenue | $816M100.00% | $495M100.00% | ULS ×1.65 |
| Gross profit | 51.10%$417M | 49.65%$246M | ULS +1.5pp |
| Operating income | 18.38%$150M | 21.85%$108M | ZWS +3.5pp |
| Pre-tax income | 41.42%$338M | 20.72%$103M | ULS +20.7pp |
| Net income |
| 31.13%$254M |
| 15.41%$76M |
| ULS +15.7pp |
No disclosed counterparties: ZWS.
None